Initial experience with silver-impregnated polyurethane ventricular catheter for shunting of cerebrospinal fluid in patients with infected hydrocephalus

Neurological Research

Volumn 31, Issue 3, 2009, Pages 234-237

  Izci, Yusuf ^a   Secer, Halilibrahim ^a   Akay, Cemal ^a   Gonul, Engin ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Hydrocephalus; Shunt infection; Silver; Ventricular catheter

Indexed keywords

POLYURETHAN; SILVER;

ADOLESCENT; ADULT; ARTICLE; BRAIN INFECTION; BRAIN VENTRICLE PERITONEUM SHUNT; CEREBROSPINAL FLUID SHUNTING; CHILD; CLINICAL ARTICLE; FOLLOW UP; HUMAN; HYDROCEPHALUS; INFANT; PERITONEAL CATHETER; PRESCHOOL CHILD; PROTEIN CEREBROSPINAL FLUID LEVEL; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; ADULT; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; CEREBROSPINAL FLUID PROTEINS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GLUCOSE; HUMANS; HYDROCEPHALUS; INFANT; MALE; MIDDLE AGED; REOPERATION; SILVER; VENTRICULOPERITONEAL SHUNT;

EID: 65749089602     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313209X380973     Document Type: Article

References (38)

1. Patwardhan RV, Nanda A. Implanted ventricular shunts in the United States: The billion-dollar-a-year cost of hydrocephalus treatment. Neurosurgery 2005; 56: 139-145 (Pubitemid 40053997)
2. Drake JM, Kestle JR, Milner R, et al. Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery 1998; 43: 294-305 (Pubitemid 28354640)
3. Kestle J, Drake J, Milner R, et al. Long-term follow-up data from the Shunt Design Trial. Pediatr Neurosurg 2000; 33: 230-236 (Pubitemid 32046018)
4. Kestle JR, Drake JM, Cochrane DD, et al. Lack of benefit of endoscopic ventriculoperitoneal shunt insertion: A multicenter randomized trial. J Neurosurg 2003; 98: 284-290
5. Davis SE, Levy ML, McComb JG, et al. Does age or other factors influence the incidence of ventriculoperitoneal shunt infections? Pediatr Neurosurg 1999; 30: 253-257
6. Choksey MS, Malik IA. Zero tolerance to shunt infections: Can it be achieved? J Neurol Neurosurg Psychiatry 2004; 75: 87-91
7. James HE, Walsh JW, Wilson HD, et al. Prospective randomized study of therapy in cerebrospinal fluid shunt infection. Neurosurgery 1980; 7: 459-463 (Pubitemid 11204863)
8. Kaufman BA. Management of complications of shunting. In: McLone DG, ed. Pediatric Neurosurgery: Surgery of the Developing Nervous System, 4th edn, Philadelphia: WB Saunders, 2001: pp. 529-547
9. Ritz R, Roser F, Morgalla M, et al. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients. BMC Infect Dis 2007; 7 (38): 1-8 (Pubitemid 46901255)
10. Crabtree JH, Burchette RJ, Siddiqi RA, et al. The efficacy of silverion implanted catheters in reducing peritoneal dialysis-related infections. Perit Dial Int 2003; 23: 368-374
11. Kim JS, Kuk E, Yu KN, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine 2007; 3: 95-101
12. Böswald M, Girisch M, Greil J, et al. Antimicrobial activity in biocompatibility of polyurethane and silicone catheters containing low concentrations of silver: A new perspective in prevention of polymer-associated foreign-body-infections. Zentralbl Bakteriol 1995; 283: 187-200
13. Brown EM, de Louvois J, Bayston R, et al. Distinguishing between chemical and bacterial meningitis in patients who have undergone neurosurgery. Clin Infect Dis 2002; 34: 556-558
14. Forgracs P, Geyer CA, Freidberg SR. Characterizing of chemical meningitis after neurological surgery. Clin Infect Dis 2001; 32: 179-185 (Pubitemid 32524785)
15. Sarguna P, Lakshmi V. Ventriculoperitoneal shunt infections. Indian J Med Microbiol 2006; 24: 52-54
16. Bhatnagar V, Mitra DK, Upadhyaya P. Shunt related infections in hydrocephalic children. Indian Pediatr 1986; 23: 255-257
17. Nicholas JL, Kamal IM, Eckstein HB. Immediate shunt replacement in the treatment of bacterial colonization of Holter valves. Dev Med Child Neurol 1970; 22: 110
18. Zabramski JM, Whiting D, Darouiche RO, et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: A prospective, randomized, controlled trial. J Neurosurg 2003; 98: 725-730
19. Sciubba D, McGirt M, Woodworth G, et al. Prolonged exposure to antibiotic-impregnated shunt catheters does not increase incidence of late shunt infections. Childs Nerv Syst 2007; 23: 867-871
20. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev 2004; 17: 255-267 (Pubitemid 38534029)
21. Galiano K, Pleifer C, Engelhardt K, et al. Silver segregation and bacterial growth of intraventricular catheters impregnated with silver nanoparticles in cerebrospinal fluid drainages. Neurol Res 2008; 30: 285-287
22. Lansdown ABG. Critical observations on the neurotoxicity of silver. Crit Rev Toxicol 2007; 37: 237-250 (Pubitemid 46442644)
23. Silver S, Phung LT. Bacterial heavy metal resistance: New surprises. Annu Rev Microbiol 1996; 50: 753-789
24. 2 glass prepared by sol-gel method. J Mater Sci Mater Med 2004; 15: 831-837
25. Zhao G, Stevens Jr SE. Multiple parameters for the comprehensive evaluation of the susceptibility of Escherichia coli to the silver ion. Biometals 1998; 11: 27-32 (Pubitemid 28039387)
26. Hamouda T, Myc A, Donovan B, et al. A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi. Microbiol Res 2000; 156: 1-7
27. Dibrov P, Dzioba J, Gosink KK, et al. Chemiosmotic mechanism of antimicrobial activity of Ag(+) in Vibrio cholerae. Antimicrob Agents Chemoter 2002; 46: 2668-2670
28. Dragieva I, Stoeva S, Stoimenov P, et al. Complex formation in solutions for chemical synthesis of nanoscaled particles prepared by borohydride reduction process. Nanostruct Mater 1999; 12: 267-270
29. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: A case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 2004; 275: 177-182
30. Amro NA, Kotra LP, Wadu-Mesthrige K, et al. High-resolution atomic force microscopy studies of the Escherichia coli outer membrane: Structural basis for permeability. Langmuir 2000; 16: 2789-2796
31. Danilczuk M, Lund A, Saldo J, et al. Conduction electron spin resonance of small silver particles. Spectrochim Acta A Mol Biomol Spectrosc 2006; 63: 189-191
32. Mc Fadden IT. Tissue reactions to standard neurosurgical metallic implants. J Neurosurg 1972; 36: 598-603
33. von Holst H, Collins P, Steiner L. Titanium, silver and tantalum clips in brain tissue. Acta Neurochir (Wien) 1981; 56: 239-242 (Pubitemid 11064912)
34. Rungby J. Experimental argyrosis: Ultrastructural localisation of silver in the rat eye. Exp Mol Pathol 1986; 45: 22-30
35. Guggenbichler JP, Böswald M, Lugauer S, et al. A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters. Infection 1999; 27 (Suppl. 1): S16-S23
36. Lackner P, Beer R, Broessner G, et al. Efficacy of silver nanoparticles-impregnated external ventricular drain catheters in patients with acute occlusive hydrocephalus. Neurocrit Care 2008; 8: 360-365
37. Samuel U, Guggenbichler JP. Prevention of catheter-related infections: The potential of a new nano-silver impregnated catheter. Int J Antimicrob Agents 2004; 23 (Suppl. 1): S75-S78
38. Gibbins B, Warner L. The role of antimicrobial silver nanotechnology. MD&DI August 2005: 112